Bausch & Lomb Petitions Patent Board To Review Eye Supplements

(May 19, 2022, 8:23 AM EDT) -- ALEXANDRIA, Va. — A patented formulation of zeaxanthin, zinc, vitamin E and vitamin C for the treatment of macular degeneration was rendered obvious or anticipated by prior art, Bausch & Lomb Inc. told the Patent Trial and Appeal Board on May 17....

Attached Documents

Related Sections